-
Innovation Ranking
NewInnovation Ranking – 10X Genomics Inc
10X Genomics Inc (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises chromium X series, chromium connect, and chromium controller. It offers services such as single-cell gene expression, single-cell immune profiling, fixed RNA profiling, single-cell multiome ATAC + gene expression, spatial gene expression, and targeted gene expression. The company also provides Barcode technology which is compatible with Single Cell Gene Expression and Immune Profiling solutions allowing researchers to simultaneously measure multiple analytes, such as...
-
Company Insights
Innovation and Patenting activity of 10X Genomics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of 10X Genomics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sizavaleucel in Kidney Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sizavaleucel in Kidney Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sizavaleucel in Kidney Transplant Rejection Drug Details: MDR-101 is under development...
-
Thematic Analysis
Banking Predictions for 2024 – Thematic Intelligence
Exploring in-depth trends and insights from the ‘Banking Predictions for 2024’ report will enable you to: Analyze the major themes that will impact the banking industry in 2024. Identify the top 20 themes impacting the banking industry – artificial intelligence, cybersecurity, the future of work, cloud computing, blockchain and cryptocurrencies, fintech, internet of things, big data, social media, financial wellness, digital lending, digital banking, conversational platforms, personalization, data privacy, and open banking. Understand a wide range of disruptive themes that...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MDR-103 in Kidney Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MDR-103 in Kidney Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MDR-103 in Kidney Transplant Rejection Drug Details:MDR-103 is under development for the...
-
Company Insights
Westpac Banking Corporation – Digital Transformation Strategies
Westpac Digital Transformation Strategies Report Overview Westpac uses cloud technologies as a part of its digital transformation strategies. The annual ICT spending of Westpac was estimated at $1.7 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Westpac Banking (Westpac) is a provider of personal, private, business, and corporate banking solutions. Its portfolio of products consists of accounts, cards, life and non-life insurance, personal and business loans, mortgages, overdraft...
-
Company Profile
Aldeyra Therapeutics Inc – Company Profile
Aldeyra Therapeutics Inc (Aldeyra Therapeutics), is a biotechnology company. It offers treatment of immune-mediated diseases. The company offers product pipeline includes Reproxalap, ADX-2191, RASP-Inhibitor Discovery Platform, ADX-629, ADX-246 and ADX-248. Reproxalap is used to treat dry eye disease, allergic conjunctivitis and proliferative vitreoretinopathy. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment primary vitreoretinal lymphoma cancer, proliferative vitreoretinopathy, and retinitis...
Add to Basket -
Company Profile
10X Genomics Inc – Company Profile
10X Genomics Inc (10X Genomics) develops an innovative genomics platform. The company’s product pipeline comprises the Chromium X series, chromium connect, and chromium controller. It offers services such as single-cell gene expression, single-cell immune profiling, fixed RNA profiling, single-cell multi-home ATAC + gene expression, spatial gene expression, and targeted gene expression. The company also provides Barcode technology which is compatible with Single Cell Gene Expression and Immune Profiling solutions allowing researchers to simultaneously measure multiple analytes, such as protein and...
Add to Basket -
Company Insights
JPMorgan Chase – Enterprise Tech Ecosystem Series
JPMorgan has been focusing on AI-based approach as a part of its digital transformation strategies. The annual ICT spending of JPMorgan was estimated at $14 billion in 2022. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. JPMorgan Chase (JPM) is a financial holding company that provides consumer and commercial banking, investment banking, financial transaction processing, and asset management solutions. The JPMorgan Digital Transformation Strategies report will act as a reference point...
-
Thematic Analysis
Cloud Computing in Banking – Thematic Intelligence
Cloud Computing in Banking Industry Thematic Overview The advantages of using cloud computing in banking industry are extensive. It helps companies to modernize infrastructure, scale operations, improve resiliency, reduce costs, and build new revenue streams and services. Cloud-based systems have helped banks adapt to the rise in remote working, increased customer app use, and associated security and fraud risks. The cloud computing in banking thematic intelligence report assesses how banking, combined with other emerging technologies, can be used across the...